Buy Rating on Lineage Therapeutics Backed by Roche Collaboration and Solid Financials

Retrieved on: 2024-05-14 19:27:19

Tags for this article:

Stem cells

Lineage Cell Therapeutics

Roche

Lineage Cell Therapeutics Inc.

Click the tags to see associated articles and topics

Buy Rating on Lineage Therapeutics Backed by Roche Collaboration and Solid Financials. View article details on hiswai:

Summary

The article discusses the positive analyst review of Lineage Cell Therapeutics by Robert W. Baird, highlighting its promising biotech advancements in stem cell research and strong financial standing. Roche's engagement reflects confidence in Lineage's innovative therapies.

Article found on: markets.businessinsider.com

View Original Article